Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program

Identifieur interne : 001D34 ( Ncbi/Curation ); précédent : 001D33; suivant : 001D35

School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program

Auteurs : Ricardo Basurto-Dávila ; Martin I. Meltzer ; Dora A. Mills ; Garrett R. Beeler Asay ; Bo-Hyun Cho ; Samuel B. Graitcer ; Nancy L. Dube ; Mark G. Thompson ; Suchita A. Patel ; Samuel K. Peasah ; Jill M. Ferdinands ; Paul Gargiullo ; Mark Messonnier ; David K. Shay

Source :

RBID : PMC:5682124

Descripteurs français

English descriptors

Abstract

Objective

To estimate the societal economic and health impacts of Maine's school‐based influenza vaccination (SIV) program during the 2009 A(H1N1) influenza pandemic.

Data Sources

Primary and secondary data covering the 2008–09 and 2009–10 influenza seasons.

Study Design

We estimated weekly monovalent influenza vaccine uptake in Maine and 15 other states, using difference‐in‐difference‐in‐differences analysis to assess the program's impact on immunization among six age groups. We also developed a health and economic Markov microsimulation model and conducted Monte Carlo sensitivity analysis.

Data Collection

We used national survey data to estimate the impact of the SIV program on vaccine coverage. We used primary data and published studies to develop the microsimulation model.

Principal Findings

The program was associated with higher immunization among children and lower immunization among adults aged 18–49 years and 65 and older. The program prevented 4,600 influenza infections and generated $4.9 million in net economic benefits. Cost savings from lower adult vaccination accounted for 54 percent of the economic gain. Economic benefits were positive in 98 percent of Monte Carlo simulations.

Conclusions

SIV may be a cost‐beneficial approach to increase immunization during pandemics, but programs should be designed to prevent lower immunization among nontargeted groups.


Url:
DOI: 10.1111/1475-6773.12786
PubMed: 29130266
PubMed Central: 5682124

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:5682124

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program</title>
<author>
<name sortKey="Basurto Vila, Ricardo" sort="Basurto Vila, Ricardo" uniqKey="Basurto Vila R" first="Ricardo" last="Basurto-Dávila">Ricardo Basurto-Dávila</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Meltzer, Martin I" sort="Meltzer, Martin I" uniqKey="Meltzer M" first="Martin I." last="Meltzer">Martin I. Meltzer</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mills, Dora A" sort="Mills, Dora A" uniqKey="Mills D" first="Dora A." last="Mills">Dora A. Mills</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0003"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Beeler Asay, Garrett R" sort="Beeler Asay, Garrett R" uniqKey="Beeler Asay G" first="Garrett R." last="Beeler Asay">Garrett R. Beeler Asay</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cho, Bo Yun" sort="Cho, Bo Yun" uniqKey="Cho B" first="Bo-Hyun" last="Cho">Bo-Hyun Cho</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Graitcer, Samuel B" sort="Graitcer, Samuel B" uniqKey="Graitcer S" first="Samuel B." last="Graitcer">Samuel B. Graitcer</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Dube, Nancy L" sort="Dube, Nancy L" uniqKey="Dube N" first="Nancy L." last="Dube">Nancy L. Dube</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Thompson, Mark G" sort="Thompson, Mark G" uniqKey="Thompson M" first="Mark G." last="Thompson">Mark G. Thompson</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Patel, Suchita A" sort="Patel, Suchita A" uniqKey="Patel S" first="Suchita A." last="Patel">Suchita A. Patel</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Peasah, Samuel K" sort="Peasah, Samuel K" uniqKey="Peasah S" first="Samuel K." last="Peasah">Samuel K. Peasah</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0005"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ferdinands, Jill M" sort="Ferdinands, Jill M" uniqKey="Ferdinands J" first="Jill M." last="Ferdinands">Jill M. Ferdinands</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Gargiullo, Paul" sort="Gargiullo, Paul" uniqKey="Gargiullo P" first="Paul" last="Gargiullo">Paul Gargiullo</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Messonnier, Mark" sort="Messonnier, Mark" uniqKey="Messonnier M" first="Mark" last="Messonnier">Mark Messonnier</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shay, David K" sort="Shay, David K" uniqKey="Shay D" first="David K." last="Shay">David K. Shay</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">29130266</idno>
<idno type="pmc">5682124</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682124</idno>
<idno type="RBID">PMC:5682124</idno>
<idno type="doi">10.1111/1475-6773.12786</idno>
<date when="2017">2017</date>
<idno type="wicri:Area/Pmc/Corpus">000693</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000693</idno>
<idno type="wicri:Area/Pmc/Curation">000693</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000693</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000201</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000201</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:29130266</idno>
<idno type="wicri:Area/PubMed/Corpus">000357</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000357</idno>
<idno type="wicri:Area/PubMed/Curation">000357</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000357</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000362</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000362</idno>
<idno type="wicri:Area/Ncbi/Merge">001D34</idno>
<idno type="wicri:Area/Ncbi/Curation">001D34</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program</title>
<author>
<name sortKey="Basurto Vila, Ricardo" sort="Basurto Vila, Ricardo" uniqKey="Basurto Vila R" first="Ricardo" last="Basurto-Dávila">Ricardo Basurto-Dávila</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0001"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Meltzer, Martin I" sort="Meltzer, Martin I" uniqKey="Meltzer M" first="Martin I." last="Meltzer">Martin I. Meltzer</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mills, Dora A" sort="Mills, Dora A" uniqKey="Mills D" first="Dora A." last="Mills">Dora A. Mills</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0003"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Beeler Asay, Garrett R" sort="Beeler Asay, Garrett R" uniqKey="Beeler Asay G" first="Garrett R." last="Beeler Asay">Garrett R. Beeler Asay</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Cho, Bo Yun" sort="Cho, Bo Yun" uniqKey="Cho B" first="Bo-Hyun" last="Cho">Bo-Hyun Cho</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Graitcer, Samuel B" sort="Graitcer, Samuel B" uniqKey="Graitcer S" first="Samuel B." last="Graitcer">Samuel B. Graitcer</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Dube, Nancy L" sort="Dube, Nancy L" uniqKey="Dube N" first="Nancy L." last="Dube">Nancy L. Dube</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0004"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Thompson, Mark G" sort="Thompson, Mark G" uniqKey="Thompson M" first="Mark G." last="Thompson">Mark G. Thompson</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Patel, Suchita A" sort="Patel, Suchita A" uniqKey="Patel S" first="Suchita A." last="Patel">Suchita A. Patel</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Peasah, Samuel K" sort="Peasah, Samuel K" uniqKey="Peasah S" first="Samuel K." last="Peasah">Samuel K. Peasah</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0005"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ferdinands, Jill M" sort="Ferdinands, Jill M" uniqKey="Ferdinands J" first="Jill M." last="Ferdinands">Jill M. Ferdinands</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Gargiullo, Paul" sort="Gargiullo, Paul" uniqKey="Gargiullo P" first="Paul" last="Gargiullo">Paul Gargiullo</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Messonnier, Mark" sort="Messonnier, Mark" uniqKey="Messonnier M" first="Mark" last="Messonnier">Mark Messonnier</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Shay, David K" sort="Shay, David K" uniqKey="Shay D" first="David K." last="Shay">David K. Shay</name>
<affiliation>
<nlm:aff id="hesr12786-aff-0002"></nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Health Services Research</title>
<idno type="ISSN">0017-9124</idno>
<idno type="eISSN">1475-6773</idno>
<imprint>
<date when="2017">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cost of Illness</term>
<term>Cost-Benefit Analysis</term>
<term>Female</term>
<term>Humans</term>
<term>Immunization Programs (economics)</term>
<term>Immunization Programs (organization & administration)</term>
<term>Infant</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza Vaccines (economics)</term>
<term>Influenza, Human (economics)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Maine (epidemiology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Models, Economic</term>
<term>Monte Carlo Method</term>
<term>Pandemics</term>
<term>School Health Services (economics)</term>
<term>School Health Services (organization & administration)</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse coût-bénéfice</term>
<term>Coût de la maladie</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (économie)</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Maine (épidémiologie)</term>
<term>Modèles économiques</term>
<term>Mâle</term>
<term>Méthode de Monte-Carlo</term>
<term>Nourrisson</term>
<term>Pandémies</term>
<term>Programmes de vaccination (organisation et administration)</term>
<term>Programmes de vaccination (économie)</term>
<term>Services de santé scolaire (organisation et administration)</term>
<term>Services de santé scolaire (économie)</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sujet âgé</term>
<term>Vaccins antigrippaux (économie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en">
<term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en">
<term>Immunization Programs</term>
<term>Influenza, Human</term>
<term>School Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Maine</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr">
<term>Programmes de vaccination</term>
<term>Services de santé scolaire</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en">
<term>Immunization Programs</term>
<term>School Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr">
<term>Grippe humaine</term>
<term>Programmes de vaccination</term>
<term>Services de santé scolaire</term>
<term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Maine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Age Factors</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Cost of Illness</term>
<term>Cost-Benefit Analysis</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Models, Economic</term>
<term>Monte Carlo Method</term>
<term>Pandemics</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse coût-bénéfice</term>
<term>Coût de la maladie</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Facteurs de l'âge</term>
<term>Femelle</term>
<term>Grippe humaine</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Modèles économiques</term>
<term>Mâle</term>
<term>Méthode de Monte-Carlo</term>
<term>Nourrisson</term>
<term>Pandémies</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="hesr12786-sec-0001">
<title>Objective</title>
<p>To estimate the societal economic and health impacts of Maine's school‐based influenza vaccination (
<styled-content style="fixed-case">SIV</styled-content>
) program during the 2009 A(H1N1) influenza pandemic.</p>
</sec>
<sec id="hesr12786-sec-0002">
<title>Data Sources</title>
<p>Primary and secondary data covering the 2008–09 and 2009–10 influenza seasons.</p>
</sec>
<sec id="hesr12786-sec-0003">
<title>Study Design</title>
<p>We estimated weekly monovalent influenza vaccine uptake in Maine and 15 other states, using difference‐in‐difference‐in‐differences analysis to assess the program's impact on immunization among six age groups. We also developed a health and economic Markov microsimulation model and conducted Monte Carlo sensitivity analysis.</p>
</sec>
<sec id="hesr12786-sec-0004">
<title>Data Collection</title>
<p>We used national survey data to estimate the impact of the
<styled-content style="fixed-case">SIV</styled-content>
program on vaccine coverage. We used primary data and published studies to develop the microsimulation model.</p>
</sec>
<sec id="hesr12786-sec-0005">
<title>Principal Findings</title>
<p>The program was associated with higher immunization among children and lower immunization among adults aged 18–49 years and 65 and older. The program prevented 4,600 influenza infections and generated $4.9 million in net economic benefits. Cost savings from lower adult vaccination accounted for 54 percent of the economic gain. Economic benefits were positive in 98 percent of Monte Carlo simulations.</p>
</sec>
<sec id="hesr12786-sec-0006">
<title>Conclusions</title>
<p>
<styled-content style="fixed-case">SIV</styled-content>
may be a cost‐beneficial approach to increase immunization during pandemics, but programs should be designed to prevent lower immunization among nontargeted groups.</p>
</sec>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D34 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001D34 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:5682124
   |texte=   School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:29130266" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a PandemieGrippaleV1 

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021